Latest filing published 10 Aug 2026 for Aptevo Therapeutics Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
SoYoung Kwon: trading record in brief
SoYoung Kwon, listed as senior executive, appears in our data through filings on Aptevo Therapeutics Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 1 June 2022 to 6 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 10 August 2026, the filings show an option exercise in Aptevo Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to SoYoung Kwon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 638 sharesCommon StockSEC:0001193125-26-343076:0
- 3 sharesCommon StockSEC:0000950170-25-097271:0
- 2 sharesCommon StockSEC:0000950170-25-032201:0
- 213 sharesCommon StockSEC:0000950170-24-094819:0
- 42 sharesCommon StockSEC:0000950170-24-068036:0
- 3,667 sharesCommon StockSEC:0000950170-24-025881:0
- 9,375 sharesCommon StockSEC:0001209191-23-045265:0
- 1,834 sharesCommon StockSEC:0001209191-23-033823:0
- 3,666 sharesCommon StockSEC:0001209191-23-016786:0
- 1,833 sharesCommon StockSEC:0001209191-22-033933:0
10 of 10 declarations